When it comes to the pharmaceutical industry, a company’s marketing or educational efforts require not just a stellar set of global plans and materials, but also the ability to adapt global
Recently, pharmaphorum spoke with Sebastian Katz, chief strategy officer of specialty healthcare company Stein Holding Group (SteinCares), to discuss the announcement of its licensing agree
Ahead of the inaugural World Without Disease Summit on Wednesday 21st June, pharmaphorum spoke with the event’s two speakers from AstraZeneca, Stefan Woxström, SVP Europe and Canada, and Stefan Vlachos, Head of Health Works
Endeavor BioMedicines has completed a third-round financing, raising an impressive $132.5 million to fund trials of its two clinical-stage drug candidates for pulmonary fi
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.